These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Small bowel obstruction by a carcinoid tumor in a patient with familial Mediterranean fever. Gabizon I; Giladi H; Ovnat A; Dukhno O; Flusser D; Sukenik S Isr Med Assoc J; 2006 May; 8(5):359-60. PubMed ID: 16805241 [No Abstract] [Full Text] [Related]
5. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. Currow DC; Quinn S; Agar M; Fazekas B; Hardy J; McCaffrey N; Eckermann S; Abernethy AP; Clark K J Pain Symptom Manage; 2015 May; 49(5):814-21. PubMed ID: 25462210 [TBL] [Abstract][Full Text] [Related]
6. How to use octreotide for malignant bowel obstruction. Ripamonti C; Mercadante S J Support Oncol; 2004; 2(4):357-64. PubMed ID: 15357519 [No Abstract] [Full Text] [Related]
7. The role of octreotide in malignant bowel obstruction. Krammer LM Oncol Nurs Forum; 1999 Jun; 26(5):831-2. PubMed ID: 10382174 [No Abstract] [Full Text] [Related]
8. Octreotide in the management of bowel obstruction in terminal ovarian cancer. Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613 [TBL] [Abstract][Full Text] [Related]
9. [Small intestine obstruction caused by primary malignant neoplasms]. Jamski J; Graca M; Orlicki P Przegl Lek; 2001; 58(10):943-4. PubMed ID: 11957825 [TBL] [Abstract][Full Text] [Related]
10. Octreotide for malignant bowel obstruction: twenty years after. Mercadante S; Porzio G Crit Rev Oncol Hematol; 2012 Sep; 83(3):388-92. PubMed ID: 22277783 [TBL] [Abstract][Full Text] [Related]
11. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction. Mercadante S J Pain Symptom Manage; 1998 Nov; 16(5):278-80. PubMed ID: 9846021 [No Abstract] [Full Text] [Related]
12. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. Jatoi A; Podratz KC; Gill P; Hartmann LC J Support Oncol; 2004; 2(4):323-34; discussion 334-7. PubMed ID: 15357517 [TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction. Shima Y; Ohtsu A; Shirao K; Sasaki Y Jpn J Clin Oncol; 2008 May; 38(5):354-9. PubMed ID: 18490369 [TBL] [Abstract][Full Text] [Related]
14. Randomised clinical trial investigating the effects of combined administration of octreotide and methylglucamine diatrizoate in the older persons with adhesive small bowel obstruction. Zhang Y; Gao Y; Ma Q; Dang C; Wei W; De Antoni F; Rocci R; Chen W Dig Liver Dis; 2006 Mar; 38(3):188-94. PubMed ID: 16311083 [TBL] [Abstract][Full Text] [Related]
15. [The treatment of carcinoid of the small intestine with octreotide and alpha-interferon. A call for participation in a randomized study]. Ahrén B Dtsch Med Wochenschr; 1996 May; 121(22):744-5. PubMed ID: 8646989 [No Abstract] [Full Text] [Related]
16. Managing nonmalignant chronic abdominal pain and malignant bowel obstruction. Bicanovsky LK; Lagman RL; Davis MP; Walsh D Gastroenterol Clin North Am; 2006 Mar; 35(1):131-42. PubMed ID: 16530116 [TBL] [Abstract][Full Text] [Related]
17. Recurrent small bowel obstruction caused by a benign tumor. A report of two cases. Ketonen P; Virkkula L; Ketonen L; Mattila S Acta Chir Scand; 1978; 144(4):261-2. PubMed ID: 706994 [TBL] [Abstract][Full Text] [Related]
18. An unusual case of malignant gastro-intestinal obstruction in advanced cervical cancer. Lübbe AS; Stange JH J Cancer Res Clin Oncol; 2002 Mar; 128(3):171-2. PubMed ID: 11935305 [No Abstract] [Full Text] [Related]